Skip to main content

Table 5 Responsiveness of women with uterine fibroids after treatment

From: Adaptability and clinical applicability of UFS-QoL in Chinese women with uterine fibroid

Subscales

Baseline

Mean score (SD)

Change in score (SD)

Effect size*

SRM†

6-month

12-month

6-month

12-month

6-month

12-month

6-months

12-months

Symptom severity

18.64 (14.24)

9.27 (9.74)

7.12 (9.15)

− 9.42 (13.29)

− 11.5

(14.21)

− 0.66

− 0.81

− 0.71

− 0.81

Concern

67.04 (21.4)

78.9 (16.63)

83.09 (15.89)

11.7

(19.35)

15.79 (22.06)

0.55

0.74

0.6

0.72

Activities

74.98 (18.05)

83.92 (13.75)

87.01 (12.85)

8.53

(16.44)

11.55 (18.53)

0.47

0.64

0.52

0.62

Energy/mood

72.38 (18.47)

81.34 (15)

84.61 (13.77)

9.04

(17.01)

12.4

(19.17)

0.49

0.67

0.53

0.65

Control

72.61 (17.15)

81.76 (14.05)

84.84 (13.28)

8.9

(16.37)

11.94 (18.59)

0.52

0.7

0.54

0.64

Self-consciousness

75.65 (18.73)

82.8 (15.74)

84.99 (14.62)

7.2

(19.14)

8.84

(20.71)

0.38

0.47

0.38

0.43

Sexual functioning

69.14 (22.05)

80.19 (20.77)

84.24 (18.9)

9.3 (23.2)

13.17 (25.73)

0.42

0.6

0.4

0.51

Total HRQL score

72.52 (15.73)

81.88 (12.81)

85.1 (11.99)

9.18 (13.75)

12.38 (16.04)

0.58

0.79

0.67

0.77

  1. HRQL health-related quality of life, SD standard deviation, SRM standardized response mean
  2. *Calculated as change in mean score divided by the standard deviation of the baseline
  3. †Calculated as change in mean score divided by the standard deviation of the change